BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 110 filers reported holding BIONTECH SE in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,653 | +27.5% | 770 | +26.6% | 0.00% | – |
| Q2 2023 | $65,622 | -97.9% | 608 | -97.6% | 0.00% | – |
| Q1 2023 | $3,109,613 | +76604.8% | 24,955 | -7.5% | 0.00% | -100.0% |
| Q4 2022 | $4,054 | -99.8% | 26,984 | +72.8% | 0.00% | – |
| Q3 2022 | $2,107,000 | -23.6% | 15,619 | -15.6% | 0.00% | – |
| Q2 2022 | $2,758,000 | -20.0% | 18,501 | -8.5% | 0.00% | – |
| Q1 2022 | $3,447,000 | -65.8% | 20,212 | -48.3% | 0.00% | -100.0% |
| Q4 2021 | $10,083,000 | +2.6% | 39,114 | +8.6% | 0.00% | 0.0% |
| Q3 2021 | $9,831,000 | +35.3% | 36,011 | +11.0% | 0.00% | 0.0% |
| Q2 2021 | $7,264,000 | +202.3% | 32,444 | +47.4% | 0.00% | – |
| Q1 2021 | $2,403,000 | -47.1% | 22,009 | -60.5% | 0.00% | -100.0% |
| Q4 2020 | $4,544,000 | +28.3% | 55,732 | +5.2% | 0.00% | 0.0% |
| Q3 2020 | $3,543,000 | +119.9% | 52,997 | +119.5% | 0.00% | – |
| Q2 2020 | $1,611,000 | +53600.0% | 24,148 | +48196.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |